← Leaderboards
Wulf Palinski
University Of California San Diego
$6,771,384
Attributed
$6,771,384
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $941.6K · FY2005–11$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$6,771,384 · 4
By mechanism
R01$3,864,279 · 2
P50$2,907,105 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of California San Diego
Same institution · by research overlap
- Beatrice A Golomb$6,262,264
- Jerrold M Olefsky$29,583,289
- Nigel Keith Woolf$2,467,831
- Robert H Tukey$19,362,771
- Andrea L Hevener$13,659,300
Others in their field
Top investigators on “Antioxidants”
- Gervasio A Lamas · Mount Sinai Medical Center (Miami Beach)$31,629,832
- Merit E Cudkowicz · Massachusetts General Hospital$31,059,060
- John James McNeil · Hennepin Healthcare Research Institute$28,037,648
- Walter C. Willett · Harvard University (Sch Of Public Hlth)$25,007,335
- Habibul Ahsan · Columbia University Health Sciences$21,519,304
- Michael A Schwarzschild · Massachusetts General Hospital$20,511,375
Research focus
AntioxidantsOxidative StressMicroscopyAtherosclerotic PlaqueHypercholesterolemiaImmunocytochemistryLaboratory MouseLow Density LipoproteinAntigensAtherosclerosisOxidationLow Density Lipoprotein ReceptorActive ImmunizationPeroxisome Proliferator Activated ReceptorApolipoprotein EAortaAnimal ModelAgonistAdultCardiovascular DiseasesBiomedical FacilityAffectBlood CirculationAntibodies
Grant awards (22)
Developmental immune programming and postnatal atherosclerosis$472,614
R01 · FY2011 · HL · contact PI
Developmental immune programming and postnatal atherosclerosis$477,394
R01 · FY2010 · HL · contact PI
Developmental immune programming and postnatal atherosclerosis$477,145
R01 · FY2009 · HL · contact PI
Developmental immune programming and postnatal atherosclerosis$467,446
R01 · FY2008 · HL · contact PI
Fetal Determinants of Atherosclerosis$499,334
R01 · FY2006 · HL · contact PI
Oxidation, immune-modulation and atherogenesis in vivo$229,216
P50 · FY2006 · HL · contact PI
Core C-- Morphology Core$126,879
P50 · FY2006 · HL · contact PI
Fetal Determinants of Atherosclerosis$496,453
R01 · FY2005 · HL
Oxidation, immune-modulation and atherogenesis in vivo$321,988
P50 · FY2005 · HL
Core C-- Morphology Core$123,182
P50 · FY2005 · HL
Fetal Determinants of Atherosclerosis$481,995
R01 · FY2004 · HL
Oxidation, immune-modulation and atherogenesis in vivo$313,026
P50 · FY2004 · HL
Core C-- Morphology Core$119,594
P50 · FY2004 · HL
Fetal Determinants of Atherosclerosis$491,898
R01 · FY2003 · HL
Oxidation, immune modulation and atherogenesis in vivo$265,067
P50 · FY2003 · HL
CORE--MORPHOLOGY$116,110
P50 · FY2003 · HL
Oxidation, immune modulation and atherogenesis in vivo$259,017
P50 · FY2002 · HL
CORE--MORPHOLOGY$112,728
P50 · FY2002 · HL
CORE--MORPHOLOGY$274,326
P50 · FY2001 · HL
ROLE OF MODIFIED LIPOPROTEINS AND THE IMMUNE SYSTEM IN ATHEROGENESIS$274,326
P50 · FY2001 · HL
CORE--MORPHOLOGY$185,823
P50 · FY2000 · HL
ROLE OF MODIFIED LIPOPROTEINS AND THE IMMUNE SYSTEM IN ATHEROGENESIS$185,823
P50 · FY2000 · HL